Showing results (41-50 of 352) with videos related to
Sort By:
Pageof 36
Revista Espanola De Cardiologia (English Ed.)|December 10, 2014
Association between anthropometry and high blood pressure in a representative sample of preschoolers in madridGloria Santos-Beneit, Mercedes Sotos-Prieto, Stuart Pocock, et al.Contemporary Clinical Trials Communications|September 25, 2023
Optimising the analysis of vascular prevention trials: Re-Assessment of the TARDIS trial, the first prevention trial to adopt an ordinal primary outcome measureLisa J Woodhouse, Alan A Montgomery, Stuart Pocock, et al.BMC Public Health|December 24, 2013
The Program SI! intervention for enhancing a healthy lifestyle in preschoolers: first results from a cluster randomized trialJosé L Peñalvo, Mercedes Sotos-Prieto, Gloria Santos-Beneit, et al.Trials|December 22, 2017
Statistical analysis plan for the 'Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage' (TICH-2) trialKatie Flaherty, Philip M Bath, Robert Dineen, et al.American Heart Journal|April 30, 2013
Rationale and design of the LEADERS FREE trial: A randomized double-blind comparison of the BioFreedom drug-coated stent vs the Gazelle bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapyPhilip Urban, Alex Abizaid, Bernard Chevalier, et al.International Journal of Stroke : Official Journal of the International Stroke Society|February 3, 2015
Statistical analysis plan for the 'Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke' (TARDIS) trialPhilip M W Bath, Katie Robson, Lisa J Woodhouse, et al.Statistics in Medicine|March 26, 2003
The use of regression models for medians when observed outcomes may be modified by interventionsIan R White, Ilona Koupilova, James CarpenterStatistics in Medicine|September 10, 2011
Identifying influential observations in Bayesian models by using Markov chain Monte CarloDan Jackson, Ian R White, James CarpenterDiabetes, Obesity & Metabolism|December 15, 2021
The effect of empagliflozin on the total burden of cardiovascular and hospitalization events in the Asian and non-Asian populations of the EMPA-REG OUTCOME trial of patients with type 2 diabetes and cardiovascular diseaseKohei Kaku, Christoph Wanner, Stefan D Anker, et al.Lancet (London, England)|August 31, 2018
Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trialAjay Gupta, Judith Mackay, Andrew Whitehouse, et al.Pageof 36